Nelesh Govender
banner
neleshg.bsky.social
Nelesh Govender
@neleshg.bsky.social
I study fungal and bacterial diseases. Prof at Wits. @nihr Global Health Research Prof. Hon Prof at MRC-CMM @uniofexeter, City-St George's and UCT. On sabbatical from NICD. MD, micro, epi 🌈
Reposted by Nelesh Govender
The meta-analysis was led by @erkison.bsky.social, with 60 wonderful co-authors contributing data, ideas and interpretations, including @neleshg.bsky.social @[email protected] @ahmedmicrobes.bsky.social @evaheinz7.bsky.social @kelwyres.bsky.social and many others not on BlueSky
November 19, 2025 at 3:52 PM
Reposted by Nelesh Govender
@neleshg.bsky.social and the Baby GERMS-South Africa team explored transmission clusters of ESKAPE pathogens across 6 South African hospitals, and identified large outbreaks of carbapenem-resistant #Klebsiella ST152 and Acinetobacter baumannii ST1 & ST2 www.medrxiv.org/content/10.1...
Enhanced detection of neonatal invasive infection clusters in South Africa using epidemiological and genomic surveillance data
Introduction Invasive bacterial infections, particularly those caused by the ESKAPE group, account for a substantial proportion of neonatal deaths in low- and middle-income countries, yet the contribu...
www.medrxiv.org
November 19, 2025 at 3:59 PM
Reposted by Nelesh Govender
We brought together teams from 13 neonatal sepsis surveillance studies, conducted across 35 sites in South Asia and Africa, to pool data and estimate prevalence of capsule and O types amongst #Klebsiella pneumoniae causing sepsis in newborns, using Bayesian modelling.
July 1, 2025 at 9:47 AM
Reposted by Nelesh Govender
Thanks for sharing.

There was also a recent State of the Art review in CID on the topic academic.oup.com/cid/article/...
State-of-the-Art Review: Use of Antimicrobials at the End of Life
Abstract. Navigating antibiotics at the end of life is a challenge for infectious disease (ID) physicians who remain deeply committed to providing patient-
academic.oup.com
May 8, 2025 at 3:24 PM
Her clinical team was reluctant to talk to us about the futility of curative treatment or end-of-life care. They wanted to continue as though she would walk out of hospital.

This didn't make sense. We wanted her to be comfortable, and not to end her life in a busy noisy bright surgical ICU.
May 8, 2025 at 1:51 PM